Investment case

INVESTORS RELATIONS

scroll

Why invest in Accrol Group Holdings plc?

  • Accrol is the market leader in the fastest growing segment of UK consumer soft tissue market, Private Label (also knows as own label).
  • Private Label comprises 50% of the total UK consumer soft tissue market, which is worth £2.1bn (retail sales)
  • Accrol has a broad customer base, focused on all retailers in the UK, with no one customer representing more than 20% of revenue.
  • The UK consumer soft tissue market is consolidating, improving the opportunity and returns for the strongest players.
  • The Group is cash generative.
  • Accrol has a very experienced and invested management team with a proven track record in transformational change, operational excellence and commercial leadership that delivers the best possible levels of return consistently.
  • The management has a keen understanding of consumer behaviour, enabling the Group to react quickly and capitalise on changing trends.
  • A relentless drive on operational efficiency and input cost management has created the strongest foundations on which to grow.
  • Accrol is well invested and operationally efficient with significant headroom for growth.

MARKET WORTH £1.6BN

PRIVATE LABEL GROWS AT 8% PER YEAR

ACCROL HAS 24% OF THIS MARKET AND GROWING

MARKET WORTH £1.6BN

PRIVATE LABEL GROWS AT 8% PER YEAR

ACCROL HAS 24% OF THIS MARKET AND GROWING

Dan Wright - Investment Case